blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2629744

EP2629744 - PRODUCT FOR TREATING CELLULITE, SKIN AGEING AND FOR PREVENTING INFLAMMATORY PROCESSES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.02.2017
Database last updated on 03.10.2024
FormerExamination is in progress
Status updated on  08.11.2016
Most recent event   Tooltip10.02.2017Application deemed to be withdrawnpublished on 15.03.2017  [2017/11]
Applicant(s)For all designated states
Gourlaouen, Brigitte
8 rue Julien Lacroix
75020 Paris / FR
[2013/35]
Inventor(s)01 / see applicant
...
 [2013/35]
Representative(s)Chantraine, Sylvie Hélène, et al
Cabinet Beau de Loménie 158, rue de l'Université
75340 Paris Cedex 07 / FR
[2013/35]
Application number, filing date11785733.419.10.2011
WO2011FR52446
Priority number, dateFR2010005853219.10.2010         Original published format: FR 1058532
[2013/35]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO2012052685
Date:26.04.2012
Language:FR
[2012/17]
Type: A1 Application with search report 
No.:EP2629744
Date:28.08.2013
Language:FR
The application published by WIPO in one of the EPO official languages on 26.04.2012 takes the place of the publication of the European patent application.
[2013/35]
Search report(s)International search report - published on:EP26.04.2012
ClassificationIPC:A61K8/23, A61K8/34, A61K8/42, A61K8/44, A61K8/49, A61K8/60, A61K8/67, A61K8/97, A61Q19/06, A61Q19/08
[2013/35]
CPC:
A61K8/23 (EP,US); A61K36/9066 (US); A23K20/10 (EP,US);
A23K20/105 (EP,US); A23K20/111 (EP,US); A23K20/142 (EP,US);
A23L2/52 (US); A23L33/10 (EP,US); A23L33/105 (EP,US);
A23L33/12 (EP,US); A23L33/135 (EP,US); A23L33/15 (EP,US);
A23L33/16 (EP,US); A23L33/175 (EP,US); A23L33/18 (EP,US);
A23L33/30 (EP,US); A61K31/353 (EP,US); A61K31/355 (EP,US);
A61K31/4525 (EP,US); A61K31/522 (EP,US); A61K36/03 (US);
A61K36/07 (US); A61K36/074 (US); A61K36/23 (US);
A61K36/41 (US); A61K36/47 (US); A61K36/484 (US);
A61K36/60 (US); A61K36/704 (US); A61K36/708 (US);
A61K36/73 (US); A61K36/77 (US); A61K36/81 (US);
A61K36/82 (US); A61K36/88 (US); A61K36/888 (US);
A61K45/06 (EP,US); A61K8/347 (EP,US); A61K8/42 (EP,US);
A61K8/44 (EP,US); A61K8/498 (EP,US); A61K8/60 (EP,US);
A61K8/645 (EP,US); A61K8/675 (EP,US); A61K8/678 (EP,US);
A61K8/9722 (EP,US); A61K8/9728 (EP,US); A61K8/9771 (EP,US);
A61K8/9789 (EP,US); A61K8/9794 (EP,US); A61P17/00 (EP);
A61P29/00 (EP); A61Q19/06 (EP,US); A61Q19/08 (EP,US);
A23V2002/00 (EP,US); A23V2200/00 (EP,US); A61K2800/884 (EP,US);
A61K2800/92 (EP,US) (-)
C-Set:
A23V2002/00, A23V2200/00, A23V2200/332, A23V2250/21 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/35]
TitleGerman:PRODUKT ZUR BEHANDLUNG VON CELLULITE, HAUTALTERUNG UND ZUR PRÄVENTION VON ENTZÜNDUNGSPROZESSEN[2013/35]
English:PRODUCT FOR TREATING CELLULITE, SKIN AGEING AND FOR PREVENTING INFLAMMATORY PROCESSES[2013/35]
French:PRODUIT DE TRAITEMENT DE LA CELLULITE, DU VIEILLISSEMENT CUTANÉ ET DE PREVENTION DES PROCESSUS INFLAMMATOIRES.[2013/35]
Entry into regional phase15.04.2013National basic fee paid 
15.04.2013Designation fee(s) paid 
15.04.2013Examination fee paid 
Examination procedure15.04.2013Amendment by applicant (claims and/or description)
15.04.2013Examination requested  [2013/35]
31.03.2016Despatch of a communication from the examining division (Time limit: M06)
11.10.2016Application deemed to be withdrawn, date of legal effect  [2017/11]
09.11.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2017/11]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  31.03.2016
Fees paidRenewal fee
22.01.2014Renewal fee patent year 03
23.10.2014Renewal fee patent year 04
14.09.2015Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.10.201303   M06   Fee paid on   22.01.2014
31.10.201606   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]EP0107885  (CRINOS INDUSTRIA FARMACO [IT]) [A] 1-20* page 6 - page 7 *;
 [A]WO0243691  (IDI IRCCS [IT], et al) [A] 1-20 * page 1, lines 1-5; example 1; claims 7-9 *;
 [A]US2003158237  (SARAGOVI URI [CA], et al) [A] 1-20 * paragraphs [0038] - [0041] - [ 102] *;
 [XA]US2006251608  (WACHSBERG RICHARD [CA], et al) [X] 21 * example 2 * [A] 1-20;
 [A]US2007212429  (HEUER MARVIN [CA], et al) [A] 1-20 * paragraphs [0057] , [0 70] - [0071] *;
 [A]WO2008011364  (LINES THOMAS CHRISTIAN [US]) [A] 1-20 * page 2, line 27 - page 4, line 24 * * page 6, lines 21-24 *;
 [ID]FR2906143  (SOUDANT ETIENNE PIERRE DOMINIQ [FR]) [ID] 1-21 * page 8, line 1 - page 10, line 13; claim - *;
 [XA]WO2009053802  (ZEHETHOFER KARL [AT]) [X] 21 * page 6; example - * * claim - * [A] 1-20;
 [A]WO2009137510  (THETA BIOMEDICAL CONSULTING & [US], et al) [A] 1-20 * paragraphs [0004] - [0007] - [0 21] - [0023]; examples 2, 4, 6, 7 *;
 [A]FR2937545  (SOUDANT ETIENNE [FR]) [A] 1-20 * page 1, lines 1-18 * * page 4, lines 16-26; example - *;
 [XA]WO2010098595  (AMOREPACIFIC CORP [KR], et al) [X] 21 * Text examples 5 and 7; paragraphs [0001] , [0 12] - [0025]; claim - * [A] 1-20
by applicantWO2004037221
 US2005136537
 WO2007104867
 FR2906143
    - MICHAUD DS; LIU S, "dietary glycemic load, Cancer Epidemiology", BIOMARKERS & PREVENTION, (2005), vol. 14, no. 1, pages 138 - 47
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.